Icotinib hydrochloride or icotinib HCl, is a first generation inhibitor of tyrosine kinase epidermal growth factor receptor (EGFR-TK). It has been used in measuring the efficacy of novel anti-cancer compounds in vivo against non-small-cell lung cancers that formed advanced solid tumors. Icotinib reversibly inhibits EGFR-TK competitively by blocking the ATP-binding site on tyrosine kinase.
MW: 427.88 g/mol
Storage/Handling: Store desiccated at 4°C.
PubChem Chemical ID: 44609731
NOT FOR HUMAN CONSUMPTION!!